European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading

MT Newswires Live07-01

European equities traded in the US as American depositary receipts were higher Monday, rising 0.55% to 1,427.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which climbed 11% and 5.5%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and travel company trivago (TRVG), which increased 3.6% and 3.5%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and software firm SAP (SAP), which dropped 4.1% and 1.3%, respectively. They were followed by telecommunications company VEON (VEON) and pharmaceutical company Ascendis Pharma (ASND), which were down 0.9% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Adaptimmune Therapeutics (ADAP), which climbed 11% and 5.6%, respectively. They were followed by biopharmaceutical company NuCana (NCNA) and financial services company Lloyds Banking Group (LYG), which were up 4.7% and 2%, respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 5.1% and 4%, respectively. They were followed by construction materials supplier CRH (CRH) and hospitality company InterContinental Hotels Group (IHG), which fell 2.6% and 2.5%, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment